⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL800422 | 0.78 | — | — | |
| SCHEMBL13063984 | 0.78 | — | — | |
| SCHEMBL10519905 | 0.78 | — | — | |
| SCHEMBL782650 | 0.78 | — | — | |
| SCHEMBL28521225 | 0.76 | — | — | |
| SCHEMBL10439892 | 0.73 | LGALS1 (0.37) | — | |
| SCHEMBL3504678 | 0.73 | IDUA (0.36) | — | |
| SCHEMBL10425613 | 0.73 | LGALS1 (0.37) | — | |
| SCHEMBL28516688 | 0.72 | ITPR3 (0.38) | — | |
| SCHEMBL6685229 | 0.69 | PYGB (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190714-A1 | PRIMARY METHODS AND PROCESSES FOR LIFE EXTENSION IN MODERN-DAY HUMANS | POSTREL RICHARD (US) | 2023-06-22 | — | — | US | claimed |
| WO-2019182549-A1 | PRIMARY METHODS AND PROCESSES FOR LIFE EXTENSION IN MODERN-DAY HUMANS | POSTREL RICHARD (US) | 2019-09-26 | — | — | WO | claimed |
| CN-118931939-A | Application of IMP anabolic gene in Porphyra haitanensis breeding | 厦门大学 | 2024-11-12 | — | — | CN | disclosed |
| CN-118853739-A | Application of IMP anabolic gene in kelp breeding | 厦门大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-118376790-A | Diagnostic marker composition for assisting in predicting acupoint catgut implantation and improving drug-withdrawal effect | 长春中医药大学 | 2024-07-23 | — | — | CN | disclosed |
| CN-116381072-B | Biomarker for identifying sporadic gout and frequent gout and application thereof | 苏州艾麦锶生命科技有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-20240175863-A1 | COMPOSITIONS AND METHODS FOR MONITORING ENPP1 ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-05-30 | — | — | US | disclosed |
| EP-4302099-A1 | COMPOSITIONS AND METHODS FOR MONITORING ENPP1 ACTIVITY | The Regents of The University of California (US) | 2024-01-10 | — | — | EP | disclosed |
| CN-117265034-A | Modularized engineering xanthine synthesis method | 阜阳师范大学 | 2023-12-22 | — | — | CN | disclosed |
| CN-116381072-A | Biomarker for identifying sporadic gout and frequent gout and application thereof | 青岛大学附属医院 | 2023-07-04 | — | — | CN | disclosed |
| US-20230190714-A1 | PRIMARY METHODS AND PROCESSES FOR LIFE EXTENSION IN MODERN-DAY HUMANS | POSTREL RICHARD (US) | 2023-06-22 | — | — | US | disclosed |
| EP-1651750-A2 | LACTOBACILLUS ACIDOPHILUS NUCLEIC ACIDS ENCODING FRUCTO-OLIGOSACCHARIDE UTILIZATION COMPOUNDS AND USES THEREOF | North Carolina State University (US) | 2006-05-03 | — | — | EP | disclosed |
| EP-1610815-A2 | FRANCISELLA STRAIN FOR LIVE VACCINE | The Secretary of State for Defence (GB) | 2006-01-04 | — | — | EP | disclosed |
| EP-1586645-A2 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | Ceres Incorporated (US) | 2005-10-19 | — | — | EP | disclosed |
| US-20050123941-A1 | Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof | NORTH CAROLINA STATE UNIVERSITY | 2005-06-09 | — | — | US | disclosed |
| WO-2005001057-A2 | LACTOBACILLUS ACIDOPHILUS NUCLEIC ACIDS ENCODING FRUCTO-OLIGOSACCHARIDE UTILIZATION COMPOUNDS AND USES THEREOF | NORTH CAROLINA STATE UNIVERSITY (US) | 2005-01-06 | — | — | WO | disclosed |
| WO-2004084935-A2 | FRANCISELLA STRAIN FOR LIVE VACCINE | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2004-10-07 | — | — | WO | disclosed |
| EP-1059354-A2 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | Ceres Incorporated (US) | 2000-12-13 | — | — | EP | disclosed |
| EP-1033405-A2 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | Ceres Incorporated (US) | 2000-09-06 | — | — | EP | disclosed |
| US-5783196-A | Gua mutants of shigella spp. and vaccines containing the same | UNIVERSITY OF MARYLAND AT BALTIMORE (US) | 1998-07-21 | — | — | US | disclosed |